Hot Stocks

The stock market changes from minute to minute, and what’s hot today may not be hot tomorrow. Our expert analysts spot hot stocks that are heating up before the crowd swoops in to bid prices higher, and our journalists sift through the noise to shine a light on trending investments -- in spaces ranging from quantum computing to marijuana stocks -- to determine whether they’re actually worth your time.

GME Stock Rises to $130. Time to Double Down or Take Profits?

By Thomas Yeung, CFA, InvestorPlace Markets Analyst
With GME stock rebounding, is it time to jump back in? The long term future could be good, but short-term speculators won't wait.

7 Education Stocks to Watch As Campuses Reopen

By Tezcan Gecgil, InvestorPlace Contributor
As more schools start to open back up, the education stocks that have stable revenue and high cash flows could stand to do well.

AMC Is a Wait-And-See Play as Streaming Services Dominate

By Lou Carlozo, InvestorPlace Contributor
Going to movies is a communal event. Your small screen or home theater cannot substitute for it, no matter how many subwoofers you install. But where AMC stock is concerned, I don't see things getting better – especially when I question what bona fide fuel went into its recent surge. 

Canoo Might Be Too Revolutionary

By Larry Ramer, InvestorPlace Contributor
Two of Canoo's innovations may turn off a high number of consumers, making GOEV stock much too risky at its current levels.

Zomedica Stock Volatility Continues as Truforma Launch Nears

By Louis Navellier and the InvestorPlace Research Staff
As Zomedica prepares to launch Truforma, its first commercial product, ZOM stock continues to experience volatility.

Nokia Has Become a Communist Utopia

By Josh Enomoto, InvestorPlace Contributor
The biggest irony with NOK stock is that the social media-driven push to save it may only be exacerbating its struggles.

Unfavorable Earnings Profile Doesn’t Bode Well for Iterum Therapeutics Stock

By David Moadel, InvestorPlace Contributor
It's encouraging that Iterum's oral antibiotic has blockbuster status potential, but the basic earnings data on ITRM stock signal caution.

Ranking the Top 7 Marijuana Stocks From Best to Worst

By Ian Bezek, InvestorPlace Contributor
Marijuana stocks are volatile right now. Cut through the noise with this ranking of seven leaders from best to worst.

It’s Not Just the Allegations That Hurt Clover Health

By Josh Enomoto, InvestorPlace Contributor
Clover Health is under fire from short seller Hindenburg Research, sending CLOV stock careening toward the ground. But that’s not the only factor to consider regarding the embattled organization.

Zomedica Continues to Fly High With Its Recent Positive Developments

By Muslim Farooque, InvestorPlace Contributor
ZOM stock has been on a tear this year, and is nearing the buy zone with the impending release of its Truforma Platform

Based on Bill Ackman’s Tweets, Pershing Square Tontine Could Be Ready to Move

By David Moadel, InvestorPlace Contributor
Bill Ackman is known for making deals and promoting businesses. His flair as a pitchman might be enough to send the PSTH stock price higher.

Nikola Requires More Progress and More Credibility Before It’s a Buy

By InvestorPlace Research Staff
NKLA stock is off sharply from its highs, but that doesn't make it cheap. With Nikola flailing, EV investors still can do better.

The Latest Analyst Downgrade Is a Buy Opportunity in BlackBerry Stock

By Louis Navellier and the InvestorPlace Research Staff
Confusingly, an analyst might downgrade a stock while hiking its price target. This happened with BB stock, which is trading cheaper now.

Despite Lofty Valuations, FIVE Stock Continues to Defy Gravity

By Dana Blankenhorn, InvestorPlace Contributor
Five Below delivers profitable growth of 16%, giving this retailer the valuation of a tech stock.

7 Blue-Chip Stocks That Look a Little Pale

By Joel Baglole, InvestorPlace Contributor
Several tried and true blue-chip stocks that performed well during the past year are starting to look a little pale lately. Is this a temporary downturn or the start of worsening trend? In this article, we look at seven blue-chip stocks that look a little pale.

SOS Ltd: Buy the Bounce or Run Like Hell?

By Thomas Yeung, CFA, InvestorPlace Markets Analyst
On Friday, SOS stock dropped 25% as short-sellers Hindenburg Research and Culper targeted the company. What should investors do next?

Loss of USPS Contract Not a Killer Blow for Workhorse Stock, But It Hurts

By InvestorPlace Staff
Workhorse lost the USPS contract, resulting in WKHS stock crashing this week, but the company has other customers for its EV delivery vans.

7 Value Stocks Ready for the Next 10 Years

By Tezcan Gecgil, InvestorPlace Contributor
These seven value stocks offer solid investment opportunities for value-conscious, patient investors with long-term portfolios.

Aurora Cannabis’ Altman Z-Score Suggests Investors Look Elsewhere

By Will Ashworth, InvestorPlace Contributor
Aurora Cannabis has an Altman Z-Score of -1.71. That means it could go bankrupt. That’s not good news for owners of ACB stock. 
Load More Articles